Immunological basis that supports the treatment of Multi-System Inflammatory Syndrome in Children (MIS-C/PIMS)
Acta Pediatrica de Mexico
; 44(2):146-160, 2023.
Artículo
en Español
| Scopus | ID: covidwho-2326706
ABSTRACT
Pediatric inflammatory multisystemic syndrome temporarily associated with COVID-19 (MIS-C/PIMS) is a new post-infectious condition, secondary to SARS-CoV2 infection. It has been characterized by an inflammatory response with multisystem involvement, involving several mechanisms of immune damage such as an exaggerated increase in cytokines and epithelial damage. Immunomodulatory treatment is aimed at controlling the manifestations of hyperinflammation, to stabilize and prevent long-term sequelae. © 2023 Instituto Nacional de Pediatria. All rights reserved.
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
Scopus
Tópicos:
Covid persistente
Idioma:
Español
Revista:
Acta Pediatrica de Mexico
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS